Each manufacturer must establish a procedure for recalling medical cannabis that has a reasonable probability of causing an unexpected or harmful response in a patient population, despite appropriate use, that outweighs the potential benefit of the medication. This procedure must include:
The commissioner may order a manufacturer to undertake a recall of a dried raw cannabis finished good. The commissioner's order must be based on a reasonable suspicion that the finished good presents a risk of causing a serious adverse incident. The commissioner must order the recall of a dried raw cannabis finished good if testing under part 4770.3035 indicates the presence of residues from a crop input prohibited under part 4770.1700 are present in the finished good. A manufacturer must comply and cooperate with any recalls ordered by the commissioner.
40 SR 1599; 46 SR 1011
June 15, 2022
Official Publication of the State of Minnesota
Revisor of Statutes